Position in OGN
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$603,768
-$1,039,811 QoQ
Shares Held
100,796
-56.0% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Philip James Wealth Mangement, LLC holds $77,068,819 across 8 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
173,727 | $22,323,919 | |
| 2 | JNJ |
Johnson & Johnson
|
81,906 | $20,801,666 | |
| 3 | NVO |
Novo Nordisk A S
|
269,741 | $12,931,383 | |
| 4 | PFE |
Pfizer Inc
|
443,426 | $10,677,698 | |
| 5 | LLY |
ELI LILLY & Co
|
4,241 | $5,086,783 | |
| 6 | AMGN |
Amgen Inc
|
8,948 | $3,240,249 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
12,976 | $1,639,387 | |
| 8 | BIIB |
Biogen Inc.
|
1,702 | $367,734 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $603,768 | 100,796 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,643,579 | 229,230 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $4,743,756 | 444,172 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $8,497,462 | 877,837 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $13,182,191 | 885,305 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $12,989,396 | 870,603 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $15,385,532 | 804,262 | Shares | Sole | 2024-10-31 | |
| No filing history on record for this holder in this stock. | ||||||